Phenmetrazine, a sympathomimetic amine, was introduced in
1956 for use as an anorexic agent. Although preparations remain available, the use
of phenmetrazine is no longer indicated for the treatment of obesity. Moreover,
since it has been subject to abuse, and because dependence can occur, it is now
controlled under Schedule II of the 1971 Convention on Psychotropic Substances.
(Reference: (UNCPS2) United Nations Convention on Psychotropic Substances (II),
, , 1971)
